Disease
14 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
This is a Phase 2 interventional trial with planned enrollment of 220 participants studying drug combinations for metastatic breast cancer; results are not reported in this registry record.
SEP 10, 2026 · PHASE 1/2 TRIAL
ClinicalTrials.gov
This is a clinical trial registry record for a Phase 1/2 umbrella study with no results posted; it describes planned enrollment and study design only.
SEP 9, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is a Phase 1, first-in-human study registration with no results posted; it describes planned enrollment and safety endpoints only, representing early-stage drug development.
AUG 19, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is a Phase 1 dose-escalation and dose-expansion trial registration with no results posted; it is a first-in-human safety and tolerability study designed to establish dosing, not efficacy.
This is a registry record for an ongoing observational study with no results reported; it describes a planned real-world evidence collection in HER2-low breast cancer but cannot yet support clinical conclusions.
AUG 17, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a recruiting Phase 3 RCT registration with no reported results; the study design is sound but outcomes are not yet available, making it a planned trial rather than evidence of efficacy.
AUG 13, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a registry record for an ongoing Phase 3 trial with no results yet reported; the study design is sound but evidence cannot be evaluated until data are available.
AUG 12, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a registry record for a planned interventional study with no results posted; enrollment has not yet begun, making it a feasibility and safety assessment in an understudied population.